Session by Mark Pearson, Deputy Director, Directorate for Employment, Labour and Social Affairs, OECD For too long, health system reforms have been built around the needs of hospitals and clinicians, rather than patients. How can we turn this around? Guided by the mandate of over thirty Ministers of Health meeting at the OECD last month, the OECD is spear-heading an international collaboration to benchmark health system performance, based on whether patients themselves say that health care has benefitted them, and to what extent. Better measuring value, however, won’t take us very far unless we also control spending and tackle waste. Drug prices are escalating and high prices do not always come with high benefits. At the same time, up to a fifth of health system spending and activities does not contribute to improving outcomes. This session will discuss how governments could re-shape the pharma industry to better respond to citizens’ needs, and tackle waste in the delivery of health care.